Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.

Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents

  • The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard in a dispute over the patents around CRISPR gene-editing technology.
  • The decision is part of a long-running legal battle brought by two universities and one of the founders of the gene-editing technique Emmanuelle Charpentier.
  • The technology dubbed CRISPR/Cas9 can cut any DNA molecule. Several companies, including Editas Medicines Inc (NASDAQ:EDIT), are among the companies that use technology licensed from Broad. 
  • The patent office has determined Broad was the first group to invent CRISPR/Cas9 for editing a certain type of human cell that can be used to make medicines—not Charpentier, the University of California (UC), and the University of Vienna. 
  • Editas CEO James Mullen said both groups made important contributions to the science that ultimately led to gene editing in medicine, but the decision "reaffirms the strength of our foundational intellectual property." 
  • The Editas license covers CRISPR/Cas9 and CRISPR/Cas12a gene-editing patents in all human cells.
  • Price Action: EDIT shares are up 2.75% at $17.59 during the market session on the last check Tuesday.
Related Stories
Intellia Therapeutics Crashes As Patent Decision Clouds CRISPR Gene-Editing Test
Intellia successfully lowered a problematic protein in patients with a liver disease on Monday, but NTLA stock fell on a…
One subscription that gives you access to news from hundreds of sites
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
Here's a roundup of top developments in the biotech space over the last 24 hours:
Researcher Portrayed In Hollywood Movie By Alec Baldwin Joins Psychedelics Company
In 2015, the movie ​​Concussion, starring Will Smith and Alec Baldwin, told the true story of a doctor and his fight against the…
Digital Workers Are Toiling Away At A Bank Near You
WorkFusion has introduced a set of digital workers that it says can perform human job roles with minimal human supervision.
What Consumers Should Ask About Precision Fermentation
Precision fermented foods produced by genetically modified microorganisms are entering the grocery marketplace. What do consumers need to know about…
One subscription that gives you access to news from hundreds of sites
Future evolution: from looks to brains and personality, how will humans change in the next 10,000 years?
READER QUESTION: If humans don’t die out in a climate apocalypse or asteroid impact in the next 10,000 years, are…